Immunomodulatory Effects of Probiotics: A Novel Preventive Approach for the Control of Bovine Mastitis
Open Access
- 14 November 2022
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 10 (11) , 2255
Abstract
Bovine mastitis (BM) is one of the most common diseases of dairy cattle, causing economic and welfare problems in dairy farming worldwide. Because of the predominant bacterial etiology, the treatment of BM is mostly based on antibiotics. However, the antimicrobial resistance (AMR), treatment effectiveness, and the cost of mastitis at farm level are linked to limitations in the antibiotic therapy. These scenarios have prompted the quest for new preventive options, probiotics being one interesting alternative. This review article sought to provide an overview of the recent advances in the use of probiotics for the prevention and treatment of BM. The cellular and molecular interactions of beneficial microbes with mammary gland (MG) cells and the impact of these interactions in the immune responses to infections are revised. While most research has demonstrated that some probiotics strains can suppress mammary pathogens by competitive exclusion or the production of antimicrobial compounds, recent evidence suggest that other probiotic strains have a remarkable ability to modulate the response of MG to Toll-like receptor (TLR)-mediated inflammation. Immunomodulatory probiotics or immunobiotics can modulate the expression of negative regulators of TLR signaling in the MG epithelium, regulating the expression of pro-inflammatory cytokines and chemokines induced upon pathogen challenge. The scientific evidence revised here indicates that immunobiotics can have a beneficial role in MG immunobiology and therefore they can be used as a preventive strategy for the management of BM and AMR, the enhancement of animal and human health, and the improvement of dairy cow milk production.Keywords
Funding Information
- Japan Society for the Promotion of Science (19H00965, 15F15401, 18F18081, 21F50394, 22F22080)
- NARO Bio-oriented Technology Research Advancement Institute (29006A)
- Japan Racing Association (15H04586, 18H02326, 21H02340)
- Challenging Exploratory Research (24658224, 26660217, 16K15021)
- JST (JPMJFS2102)
This publication has 100 references indexed in Scilit:
- Escherichia coli- and Staphylococcus aureus-induced mastitis differentially modulate transcriptional responses in neighbouring uninfected bovine mammary gland quartersBMC Genomics, 2013
- Host-response patterns of intramammary infections in dairy cowsVeterinary Immunology and Immunopathology, 2011
- Treatment of Infectious Mastitis during Lactation: Antibiotics versus Oral Administration of Lactobacilli Isolated from Breast MilkClinical Infectious Diseases, 2010
- Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary glandBMC Genomics, 2010
- Association ofEscherichia coliJ5-Specific Serum Antibody Responses with Clinical Mastitis Outcome for J5 Vaccinate and Control Dairy CattleClinical and Vaccine Immunology, 2009
- Administration of a live culture ofLactococcus lactisDPC 3147 into the bovine mammary gland stimulates the local host immune response, particularlyIL-1β andIL-8gene expressionJournal of Dairy Research, 2009
- The capacity of bovine endothelial cells to eliminate intracellularStaphylococcus aureusandStaphylococcus epidermidisis increased by the proinflammatory cytokines TNF-α and IL-1βFEMS Immunology & Medical Microbiology, 2008
- Costs of mastitis: facts and perceptionJournal of Dairy Research, 2008
- Treating mastitis in the cow - a tradition or an archaismJournal of Applied Microbiology, 2005
- Antibody Production by Human Colostral CellsScandinavian Journal of Immunology, 1975